These 3 Dividend Stocks Are Undervalued And Poised To Rebound To $100 Per Share
Published Jul 15, 2020 on Seeking Alpha

Seeking AlphaQuick Picks & ListsThese 3 Dividend Stocks Are Undervalued And Poised To Rebound To $100 Per ShareJul. 15, 2020 10:16 AM ET|| Includes: BUD, CVS, RHPby: HawkinvestHawkinvest Value, contrarian, dividend investingSummaryThe market is up big from the March lows, but many stocks could have significant upside when a vaccine is announced, or the virus is contained.
It's important to remember that no pandemic has ravaged mankind or the economy for very long, and this too shall fade one way or the other.
When the virus is a diminished risk, all that will be left is extremely low interest rates, and investors who are starved for yield will buy dividend stocks.
The continued spread of the virus is creating negative headlines which is giving us a buying opportunity, but there is also lots of good news in terms of vaccine development.
It can pay off big to be a contrarian; often it's best to buy when the headlines are terrible.
The stock market has had a strong rally since the March lows, but there are still some incredible buying opportunities for investors who believe that a vaccine is coming in the next several months or so. The tech sector has been leading the rally and a number of stocks in this industry have reached record highs. That could be an indication that the market is forecasting a return to normalcy in the not too distant future. If this is the case, there are many stocks that could play catch up and also be poised to hit record highs as soon as a successful vaccine is announced, or when the virus appears to be contained as it now seems to be in many countries including China.
I realize that there is always some possibility that a vaccine will not be formulated for Coronavirus, but I think the chance of that is small. There are so many companies working on this, so the odds are that an effective or even partially effective vaccine will help to conquer this global pandemic. It's also worth noting that no pandemic has ever lasted for... Read more